Research programme: microbial therapeutics - Federation Bio
Latest Information Update: 05 Feb 2021
At a glance
- Originator Federation Bio
- Class Antineoplastics; Bacteria; Gene therapies; Immunotherapies
- Mechanism of Action Immunomodulators; Oxalate inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hyperoxaluria
- Research Cancer